-
Health State Utilities Associated With Geographic Atrophy Secondary to Dry Age-Related Macular Degeneration
Sep 9, 2025, 16:22 PM -
Integrating Equity and Efficiency in Health Economic Evaluation: Development of Equity-Informed Methodologies in the French Healthcare Context (INEES Project)
Sep 9, 2025, 16:22 PM -
The Epidemiology Burden and Management of Chronic Hand Eczema in Adolescents: A Systematic Literature Review
Sep 9, 2025, 16:22 PM -
Reevaluating Cost-Effectiveness: A Holistic Framework for Assessing Disease-Modifying Treatments in Type 1 Diabetes
Sep 9, 2025, 16:22 PM -
Clinical Humanistic and Economic Burden Menopause-Related Vasomotor Symptoms: A Targeted Literature Review
Sep 9, 2025, 16:22 PM -
Fair Pricing of Innovative Medicines From Definition to Application in CAR-T Cell Therapy
Sep 9, 2025, 16:22 PM -
Association Between Objective Response and Overall Survival in BRAF V600e-Mutant Metastatic Colorectal Cancer: An Analysis of the BEACON CRC Trial
Sep 9, 2025, 16:22 PM -
A Proof of Concept Study to Build a Japanese-Based Electronic Medical Record Data Model Suited for Real-World Research
Sep 9, 2025, 16:22 PM -
Gaps in Evidence on Burden and HRQoL in Small-Cell Lung Cancer: Findings From a Targeted Literature Review
Sep 9, 2025, 16:22 PM -
Economic Burden of Progressive Pulmonary Fibrosis (PPF) in the Brazilian Private Healthcare System
Sep 9, 2025, 16:22 PM -
National Competent Authorities’ Experiences With Early Feasibility Study Assessment: Promoting Dialogue, Supporting Sponsors, and Fostering Shared Learning to Harmonize the EU Framework
Sep 9, 2025, 16:22 PM -
Characterization of the Distribution of Body Mass Index in Portuguese People With Type 2 Diabetes
Sep 9, 2025, 16:22 PM -
Direct Healthcare Costs (HCCs) Inequalities Associated With Myasthenia Gravis (MG) in Hungary: Claims Database Analysis
Sep 9, 2025, 16:22 PM -
Inducing Labor in Denmark: A Descriptive Study
Sep 9, 2025, 16:22 PM -
Innovative Drug Access in Portugal: An Analysis of Managed Entry Agreements Supporting Public Coverage 2014-2024
Sep 9, 2025, 16:22 PM -
Associations of Product-Specific and Clinical Evidence Quality Characteristics With Health Technology Assessment Outcomes: A Quantitative Assessment of Appraisals for Drugs for Rare Diseases in England and Germany
Sep 9, 2025, 16:22 PM -
Assessing the Real-World Impact of Earlier Initiation of Anti-Tumor Necrosis Factor vs. Conventional Synthetic DMARDs on Clinical and Patient-Reported Outcomes in Patients With Rheumatoid Arthritis in Europe
Sep 9, 2025, 16:22 PM -
The Soft Science in Hard Decisions: Utility of Qualitative Evidence in HTA Decisions
Sep 9, 2025, 16:22 PM -
Treatments for Children With Newly Diagnosed Medulloblastoma: A Systematic Review Of Randomized Controlled Trials
Sep 9, 2025, 16:22 PM -
Give Us the Tools and We Will Finish the Job: How Accurate Is AI for Study Selection in Systematic Reviews?
Sep 9, 2025, 16:22 PM
